-- 
Bavarian Gets Rights to New Cancer Vaccine Product Candidates

-- B y   C h r i s t i a n   W i e n b e r g
-- 
2011-10-05T15:03:24Z

-- http://www.bloomberg.com/news/2011-10-05/bavarian-gets-rights-to-new-cancer-vaccine-product-candidates.html
Bavarian Nordic A/S said its BN
ImmunoTherapeutics subsidiary has agreed with the  National
Cancer Institute  to jointly develop new off-the-shelf product
candidates for the treatment of multiple cancers and a new
technology platform based on NCIâ€™s cancer vaccine technology.   To contact the editor responsible for this story:
Christian Wienberg at 
 cwienberg@bloomberg.net  